Investigation of the first outbreak of OXA-48-producing Klebsiella pneumoniae in Ireland

Journal of Hospital Infection

Volumn 87, Issue 1, 2014, Pages 41-46

  Wrenn, C ^a   O'Brien, D ^a   Keating, D ^a   Roche, C ^b   Rose, L ^b   Ronayne, A ^a   Fenelon, L ^a   Fitzgerald, S ^a   Crowley, B ^b   Schaffer, K ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

Carbapenemase producing enterobacteriaceae; Healthcare setting; Klebsiella; Outbreak; OXA 48 carbapenemase

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COLISTIN; ERTAPENEM; FOSFOMYCIN; GENTAMICIN; MEROPENEM; OXACILLINASE 48; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; BETA LACTAMASE; OXACILLINASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CLONE; EPIDEMIC; HOSPITAL PATIENT; HUMAN; IRELAND; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OXACILLINASE 48 PRODUCING KLEBSIELLA PNEUMONIAE; PULSED FIELD GEL ELECTROPHORESIS; SURGICAL PATIENT; CLASSIFICATION; ENZYMOLOGY; EPIDEMIOLOGY; GENETICS; INFECTION CONTROL; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; PROCEDURES; SECRETION (PROCESS); TERTIARY CARE CENTER;

BETA-LACTAMASES; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; ENVIRONMENTAL MICROBIOLOGY; HUMANS; INFECTION CONTROL; IRELAND; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; TERTIARY CARE CENTERS;

EID: 84899919317     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2014.03.001     Document Type: Article

References (29)

1. Nordmann P., Gniadkowski M., Giske C.G., Poirel L., Woodford N., Miriagou V. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 2012, 18:432-438. European Network on Carbapenemases.
2. Cantón R., Akóva M., Carmeli Y., et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012, 18:413-431.
3. Carrër A., Poirel L., Yilmaz M., et al. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother 2008, 52:2950-2954.
4. Thomas C.P., Elamin N., Doumith M. Hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the United Kingdom. Abstracts of the forty-ninth interscience conference on antimicrobial agents and chemotherapy, San Francisco, CA, USA 2009, American Society for Microbiology, Washington, DC, USA, Abstract C2-648.
5. Cuzon G., Ouanich J., Gondret R., Naas T., Nordmann P. Outbreak of OXA-48 positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 2011, 55:2420-2423.
6. Pitart C., Solé M., Roca I., Fàbrega A., Vila J., Marco F. First outbreak of a plasmid-mediated carbapenem-hydrolysing OXA-48 b-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother 2011, 55:4398-4401.
7. Glupczynski Y., Huang T.D., Bouchahrouf W., et al. Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. Int J Antimicrob Agents 2012, 39:168-172.
8. Goren M.G., Chmelnitsky I., Carmeli Y., Navon-Venezia S. Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel. JAntimicrob Chemother 2011, 66:672-673.
9. Sukhorukova M., Savochkina J., Alexandrova I., Timohova A., Edelstein M. First outbreak of carbapenem-resistant OXA-48-producing Klebsiella pneumoniae in Russia [abstract R2508]. Abstracts of the 22nd European Congress of Clinical Microbiology and Infectious Diseases 2012, ESCMID, London, UK.
10. Potron A., Kalpoe J., Poirel L., Nordmann P. European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone. Clin Microbiol Infect 2011, 17:E24-E26.
11. Grundmann H., Livermore D.M., Giske C.G., et al. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill 2010, 15(46). pii=19711.
12. Morris D., Boyle F., Morris C., et al. Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland. JAntimicrob Chemother 2012, 67:2367-2372.
13. Roche C., Cotter M., O'connell N., Crowley B. First identification of class a carbapenemase-producing Klebsiella pneumoniae in the Republic of Ireland. Euro Surveill 2009, 14(13). pii=19163.
14. Prior A.R., Roche C., Lynch M., Kelly S., O'rourke K., Crowley B. First identified case of VIM-producing carbapenem-resistant Klebsiella pneumoniae in the Republic of Ireland associated with fatal outcome. Euro Surveill 2010, 15(50). pii=19752.
15. Mcdermott H., Morris D., Mcardle E., et al. Isolation of NDM-1 producing Klebsiella pneumoniae in Ireland, July 2011. Euro Surveill 2012, 17(7). pii=20087.
16. O'brien D.J., Wrenn C., Roche C., et al. First isolation and outbreak of OXA-48-producing Klebsiella pneumoniae in an Irish hospital, March to June 2011. Euro Surveill 2011, 16(29). pii=19921.
17. Performance standards for antimicrobial susceptibility testing: 21st informational supplement January 2011, vol. 31. Clinical Laboratory Standards Institute (CLSI), CLSI document M100-S21, No. 1.
18. Cohen S.J., Leverstein-Van Hall M.A. Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents 2010, 36:205-210. Dutch Working Party on the Detection of Highly Resistant Microorganisms.
19. Laboratory protocol for detection of carbapenem-resistant or carbapenemase-producing, Klebsiella spp. and E. coli from rectal swabs 2009, Centers for Disease Control and Prevention (CDC), US Department of Health and Human Services, CDC, Atlanta, GA.
20. Kaczmarek F.M., Dib-Hajj F., Shang W., Gootz T.D. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother 2006, 50:3396-3406.
21. Diancourt L., Passet V., Verhoef J., Grimont P.A., Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. JClin Microbiol 2005, 43:4178-4182.
22. Woodford N., Eastaway A.T., Ford M., et al. Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae. JClin Microbiol 2010, 48:2999-3002.
23. EUCAST breakpoint tables for interpretation of MICs and zone diameters January 5, 2011, European Committee on Antimicrobial Susceptibility Testing (EUCAST), Version 1.3.
24. Österblad M., Kirveskari J., Hakanen A.J., Tissari P., Vaara M., Jalava J. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11). JAntimicrob Chemother 2012, 67:2860-2864.
25. Marcade G., Brisse S., ialek S., et al. The emergence of multidrug-resistant Klebsiella pneumoniae of international clones ST13, ST16, ST35, ST48 and ST101 in a teaching hospital in the Paris region. Epidemiol Infect 2013, 141:1705-1712.
26. Diestra K., Miró E., Martí C., et al. Multiclonal epidemic of Klebsiella pneumoniae isolates producing DHA-1 in a Spanish hospital. Clin Microbiol Infect 2011, 17:1032-1036.
27. Poirel L., Potron A., Nordmann P. OXA-48-like carbapenemases: the phantom menace. JAntimicrob Chemother 2012, 67:1597-1606.
28. Dimou V., Dhanji H., Pike R., Livermore D.M., Woodford N. Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK. JAntimicrob Chemother 2012, 67:1660-1665.
29. Anonymous Guidelines for the prevention and control of multi-drug resistant organisms (MDRO) excluding MRSA in the healthcare setting February 2013, Health Protection Surveillance Centre, Dublin.